HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data.
about
Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B.Pronounced decline of serum HBsAg in chronic hepatitis B patients with long-term effective nucleos(t)ide analogs therapy.Hepatitis B s antigen kinetics during treatment with nucleos(t)ides analogues in patients with hepatitis B e antigen-negative chronic hepatitis B.
P2860
HBsAg level and clinical course in patients with chronic hepatitis B treated with nucleoside analogue: five years of follow-up data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
HBsAg level and clinical cours ...... five years of follow-up data.
@ast
HBsAg level and clinical cours ...... five years of follow-up data.
@en
type
label
HBsAg level and clinical cours ...... five years of follow-up data.
@ast
HBsAg level and clinical cours ...... five years of follow-up data.
@en
prefLabel
HBsAg level and clinical cours ...... five years of follow-up data.
@ast
HBsAg level and clinical cours ...... five years of follow-up data.
@en
P2093
P2860
P1476
HBsAg level and clinical cours ...... : five years of follow-up data
@en
P2093
Hee Won Moon
So Young Kwon
Soon Young Ko
Won Hyeok Choe
Yun Jung Choi
P2860
P304
P356
10.3350/CMH.2013.19.4.409
P577
2013-12-28T00:00:00Z